April 21, 2017 (Medical News Today) André Veillette and a team of researchers at the Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical Research Institute have discovered why …
Why Does Immunotherapy Work in Some Patients but not in Others? Read More
January 19, 2017 (Discovery Medicine) Sarcomas are rare and aggressive malignancies of bone and soft tissue affecting all ages of patients that are usually incurable when non-responsive to chemotherapy and …
Advances in Treating Sarcoma with Immunotherapy Read More
CAR T-Cell Therapy: How It Works Chimeric antigen receptor (CAR) T-cell therapy is an investigational form of immunotherapy — in fact, the first gene therapy — if FDA-approved. CAR T …
CAR-T Cell Therapy HCP Guide – Mechanism of Action Read More
December 17, 2015 (Leukemia & Lymphoma Society) Dr. Steven Rosenberg explains why immunotherapies provides the best clues for cancer treatments for patients who can’t be helped by current drugs.
VIDEO: Dr. Steven Rosenberg on saving lives with Car T Therapy Read More
What is the most common adverse effect of chimeric antigen receptor therapy (CAR-T)? A. Reactivation of tuberculosis B. Stevens-Johnson syndrome C. Cytokine release syndrome D. Neurotoxicity Click for the answer …
StatPearls Question of the Week #2 Read More
April 26, 2017 (Medical News Today) Cellular therapy hasn’t had much success in fighting solid tumors, partly because it’s been difficult to deliver anti-cancer T cells to the tumors. A …
Implanted scaffold with T cells rapidly shrinks tumors Read More
November 13, 2015 (ImedexCME) ImedexCME thorough video on the differences in CAR-T techniques.
VIDEO: CAR-T Cell Therapies for CLL: How are the various techniques different? Read More
April 25, 2017 (Medical News Today) The researchers call their approach “minimalist nanovaccine.” It is a simple mixture of the tumor antigen (molecules that uniquely identify the cancer target) and …
Nanovaccine shows potential as immunotherapy for cancer Read More